MOLECULAR-BASIS OF THE X-CHROMOSOME-LINKED KALLMANNS SYNDROME

被引:5
|
作者
PETIT, C
机构
[1] Christine Petit is at the Unit for Molecular Human Genetics, Institut Pasteur
来源
TRENDS IN ENDOCRINOLOGY AND METABOLISM | 1993年 / 4卷 / 01期
关键词
D O I
10.1016/1043-2760(93)90057-L
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Kallmann's syndrome combines hypogonadotropic hypogonadism and anosmia. The most frequent form of the disease is linked to the X chromosome and has been proposed to be due to a defect in the embryonic migration of GnRH neurons and olfactory axons from the nose to the brain. A candidate gene for the X-linked form of the disease has been isolated by positional cloning. Mutations in the open reading frame have been identified in several patients, providing convincing evidence that this gene is the actual gene, KAL, responsible for the X-linked Kallmann's syndrome. Correlations between molecular and clinical data extend the role of the KAL gene to other neuronal pathways and kidney organogenesis. The deduced amino acid sequence led us to postulate that the KAL protein is an extracellular matrix component with possible antiprotease and adhesion functions. Such functions are known to be involved in neuronal migration, axonal guidance and targeting, and also in synaptogenesis. Further experiments will enable the elucidation of the role of the KAL protein.
引用
收藏
页码:8 / 13
页数:6
相关论文
共 50 条
  • [1] A MOLECULAR APPROACH TO THE PATHOPHYSIOLOGY OF THE X-CHROMOSOME-LINKED KALLMANNS-SYNDROME
    HARDELIN, JP
    PETIT, C
    BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM, 1995, 9 (03): : 489 - 507
  • [2] EDITORIAL - X-CHROMOSOME-LINKED KALLMANNS SYNDROME - PATHOLOGY AT THE MOLECULAR-LEVEL
    PRAGER, D
    BRAUNSTEIN, GD
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (04): : 824 - 826
  • [3] THE X-CHROMOSOME-LINKED KALLMANNS-SYNDROME - THE KAL GENE IS INVOLVED IN THE DEVELOPMENT OF THE CENTRAL OLFACTORY SYSTEM
    LEGOUIS, R
    HARDELIN, JP
    LEVILLIERS, J
    AYER, C
    PETIT, C
    CHEMICAL SENSES, 1995, 20 (01) : 178 - 179
  • [4] HETEROGENEITY IN THE MUTATIONS RESPONSIBLE FOR X-CHROMOSOME-LINKED KALLMANN SYNDROME
    HARDELIN, JP
    LEVILLIERS, J
    BLANCHARD, S
    CAREL, JC
    LEUTENEGGER, M
    PINARDBERTELLETTO, JP
    BOULOUX, P
    PETIT, C
    HUMAN MOLECULAR GENETICS, 1993, 2 (04) : 373 - 377
  • [5] THE MOLECULAR-BASIS OF X-LINKED IMMUNODEFICIENCY DISEASE
    KINNON, C
    LEVINSKY, R
    JOURNAL OF INHERITED METABOLIC DISEASE, 1992, 15 (04) : 674 - 682
  • [6] X-CHROMOSOME-LINKED KALLMANN SYNDROME - STOP MUTATIONS VALIDATE THE CANDIDATE GENE
    HARDELIN, JP
    LEVILLIERS, J
    DELCASTILLO, I
    COHENSALMON, M
    LEGOUIS, R
    BLANCHARD, S
    COMPAIN, S
    BOULOUX, P
    KIRK, J
    MORAINE, C
    CHAUSSAIN, JL
    WEISSENBACH, J
    PETIT, C
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (17) : 8190 - 8194
  • [7] MOLECULAR-BASIS OF CHROMOSOME ABERRATION
    KANDA, N
    CELL STRUCTURE AND FUNCTION, 1985, 10 (04) : 457 - 457
  • [8] X-CHROMOSOME-LINKED ADULT BULBOSPINAL NEURONOPATHY
    MOZOLEVSKY, YV
    ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 1989, 89 (03): : 121 - 123
  • [9] MOLECULAR-BASIS FOR 3 X-LINKED IMMUNE DISORDERS
    PUCK, JM
    HUMAN MOLECULAR GENETICS, 1994, 3 : 1457 - 1461
  • [10] ISOLATION AND CHARACTERIZATION OF THE GENE RESPONSIBLE FOR THE X-CHROMOSOME-LINKED KALLMANN-SYNDROME
    LEGOUIS, R
    COHENSALMON, M
    DELCASTILLO, I
    PETIT, C
    BIOMEDICINE & PHARMACOTHERAPY, 1994, 48 (5-6) : 241 - 246